Search results
Why Casualty's mental health series is important television
Digital Spy via Yahoo News· 2 days agoThis series has also highlighted how the system is failing patients with mental health conditions...
Girl, 15, found dead in 'unknown person's driveway' in SF
San Francisco Chronicle· 20 hours agoEast Bay teen Jazmin Pellegrini, 15, was found dead in San Francisco’s Oceanview neighborhood on...
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of...
FOX 23 News Albany· 1 day agoAlkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in patients with ...
Biohaven (NYSE:BHVN) Shares Gap Up on Insider Buying Activity
ETF DAILY NEWS· 18 hours agoBiohaven Ltd. (NYSE:BHVN – Get Free Report)’s share price gapped up prior to trading on Tuesday following insider buying activity. Biohaven shares last traded at $39.49, with a volume of 325,573 ...
From politics to the lab: The push for psychedelics in Mass.
WBUR Boston· 2 days agoLawmakers are wrestling with a proposed ballot question seeking to decriminalize the use of certain...
US Supreme Court reportedly declines to hear Vanda patent case (NASDAQ:VNDA)
Seeking Alpha· 3 days agoThe US Supreme Court has reportedly declined to hear Vanda Pharmaceuticals' (VNDA) case regarding...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 15 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Zacks· 4 days agoAlkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoAlkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in patients with ...
The Baby Blues vs. Postpartum Depression: Similarities and Differences
Healthline· 1 day agoThe baby blues, or feeling down, tired, and overwhelmed after giving birth, are common. Feeling some...
